Helix BioMedix Inc Sustainability Reports
Helix BioMedix, Inc. is a biopharmaceutical company focused on the discovery and early-stage development of peptide-based therapeutics, with a primary focus on rare dermatological conditions and skin health, including the development of HB4208 for xeroderma pigmentosum.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG001S7VV35
2 reports from 2008 to 2024
Company Profile
Helix BioMedix, Inc. is a biopharmaceutical company focused on the discovery and early-stage development of peptide-based therapeutics, with a primary focus on rare dermatological conditions and skin health, including the development of HB4208 for xeroderma pigmentosum.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
